IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 460 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1760    
    Printed77    
    Emailed2    
    PDF Downloaded156    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1985  |  Volume : 17  |  Issue : 2  |  Page : 98-102

Neuroleptic therapy and antihistaminic drugs: a pharmacological study



Correspondence Address:
T J Hemnani


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

(1) The antipsychotic effects of chlorpromazine have been potentiated by mepyramine and pheniramine, unaffected by diphenhydramine and meclizine, while it is antagonised by promethazine. (2) Regarding extrapyramidal effects, promethazine, diphenhydramine and mepyramine have strong antagonising effect as compared to pheniramine and meclizine. (3) Comparison of risk-benefit ratio, suggest that during neuroleptic therapy, the prophylactic use of promethazine has harmful effect, diphenhydramine and meclizine have no effect, while mepyramine and pheniramine have a beneficial effect.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow